Project Details
| Short title | B9991025 |
|---|---|
| Status | Finished |
| Effective start/end date | 19/07/18 → 5/01/21 |
A Phase 1B/2 study to evaluate safety and anti-tumour activity of AVELUMAB in combination with POLY (ADENOSINE DIPHOSPHATE [ADP]-RIBOSE) POLYMERASE (PARP) inhibitor TALAZOPARIB in patients with locally advance or metastatic solid tumours
- Sabanathan, Dhanusha (Primary Chief Investigator)
- Kefford, Richard (Chief Investigator)
- Butala, Radhika (Research Coordinator)
- Cunningham, Jacob (Other)
Project: Research